Latest Industry Insights

Researchers have made significant strides toward developing improved battery chemistries, but scaling up production is challenging. To find out more, we spoke to Zhao Liu, senior market development manager at Thermo Fisher Scientific.

Technology Networks recently spoke with Tom Schafer, Vice President at Koch Modular Process Systems, to learn more about the pongamia tree, how its bitter taste can be processed out and the potential uses for pongamia oil.

At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.

At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.

Unlocking more information from our proteome could deepen our understanding of disease, improve detection and influence drug selection. To find out more about single-molecule proteomics, we spoke to Parag Mallick, co-founder of Nautilus Biotech.

Technology Networks spoke with Dr. Sarah Inglis, trial manager of a recent study investigating the safety of a common ADHD medication, methylphenidate, in children and adolescents.

At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.

To learn more about MIPS and why they are particularly suited for use in in vitro diagnostic assays, we spoke to Dr. Francesco Canfarotta, head of chemistry at MIP Discovery.

The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.

To learn more about the application of AI across all stages of development, from drug design to clinical trials, Technology Networks spoke with Dr. Yuan Wang, head of research analytics at UCB.